Lonza
Vincent Jannin is an accomplished professional with extensive experience in pharmaceutical research and development. Currently, Vincent serves as the Director of R&D and Head of the Innovaform™ Accelerator at Lonza, where leadership includes founding the Accelerator and overseeing a state-of-the-art R&D facility. Prior roles include Manager of Oral Drug Delivery Innovation and Research Director at Gattefossé, where strategic planning and innovation leadership led to significant advancements in pharmaceutical technologies. Additionally, Vincent contributed to academia as a lecturer at CPE Lyon and Université Claude Bernard Lyon 1, sharing expertise in formulations. Vincent holds multiple advanced degrees in Pharmaceutical Sciences and has completed a certificate in Strategic Management from EDHEC Business School.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.